Authors/Disclosures
|
Mia T. Minen, MD, FAAN
(NYULMC Neurology)
|
The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI . |
|
|
No disclosure on file |
|
Brandon P. Foreman, MD
(University of Cincinnati)
|
Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell, Inc. Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Consultant for Natus Medical Incorporated. Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Consultant for Immedica, Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sophysa, Inc. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Foreman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma Inc.. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Reminger Co, LPA. The institution of Dr. Foreman has received research support from DOD/AMRMC. The institution of Dr. Foreman has received research support from Biogen, Inc.. The institution of Dr. Foreman has received research support from DOD/AFRL. The institution of Dr. Foreman has received research support from NSF SCH:INT. The institution of Dr. Foreman has received research support from NIH/NIBIB. The institution of Dr. Foreman has received research support from DOD/JWMRP. The institution of Dr. Foreman has received research support from Marinus Pharmaceuticals. The institution of Dr. Foreman has received research support from PCORI. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Natus Medical Incorporated. Dr. Foreman has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with Ceribell, Inc.. Dr. Foreman has received personal compensation in the range of $0-$499 for serving as a Peer-to-peer program honoraria with Marinus Pharmaceuticals. |
|
Rajeev Motiwala, MD, FAAN
(NYU Langone School of Medicine)
|
Dr. Motiwala has nothing to disclose. |
|
Seth L. Pullman, MD, FAAN
(Columbia University)
|
No disclosure on file |
|
Michael G. Case, MS
(Eli Lilly and Company)
|
Mr. Case has received personal compensation for serving as an employee of Eli Lilly and Company. Mr. Case has received stock or an ownership interest from Eli Lilly and Company. |
|
|
No disclosure on file |
|
Amer Malik, MD
(University of Miami Miller School of Medicine)
|
Dr. Malik has nothing to disclose. |
|
Blair Ford, MD, FAAN
(Columbia University)
|
No disclosure on file |